KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹590 Cr | ₹446 Cr | ₹394 Cr | ₹354 Cr | ₹341 Cr |
What is the latest Total Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹590 Cr |
| Mar2025 | ₹446 Cr |
| Mar2024 | ₹394 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹341 Cr |
How is Total Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹590 Cr | 32.32 | |
| Mar2025 | ₹446 Cr | 13.06 | |
| Mar2024 | ₹394 Cr | 11.47 | |
| Mar2023 | ₹354 Cr | 3.83 | |
| Mar2022 | ₹341 Cr | - | |
Compare Total Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,417.2 Cr | -2.6% | 27.1% | 226.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -2.6% |
27.1% |
226.7% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses